Back to dashboard
Low impact

Risankizumab-rzaa (Skyrizi) (CPB 1009, reviewed 2026-07-01)

Aetna·Medical Policy
Effective date
Not stated
We identified it
Aug 16, 2026
Days to comply
—

Related policy hubs